DIASOME PHARMACEUTICALS, INC.

Profile

Company Names

DIASOME PHARMACEUTICALS, INC.
DIASOME PHARMACEUTICALS LLC

Addresses

10000 CEDAR AVENUE, SUITE 6, CLEVELAND, OH 44106

625 RIDGE PIKE, SUITE 402, CONSHOHOCKEN, PA 19428

Phone Numbers

216-444-7110
610.923.9443

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER, BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

PA

Total Amount Raised:

$62,535,117.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-07-31 
$3,090,740.00 
$15,555,620.00 
$12,464,880.00 
Equity 
7
2023-06-22 
$8,999,998.00 
$14,999,998.00 
$6,000,000.00 
Equity 
6
2022-08-26 
$16,724,591.00 
$19,092,510.00 
$2,367,919.00 
Equity 
5
2020-09-21 
$1,500,000.00 
$5,000,000.00 
$3,500,000.00 
Debt 
4
2020-03-17 
$2,885,788.00 
$2,897,788.00 
$12,000.00 
Equity 
3
2018-10-12 
$12,084,000.00 
$18,638,000.00 
$6,554,000.00 
Debt 
2
2016-12-16 
$4,350,000.00 
$8,000,000.00 
$3,650,000.00 
Debt 
1
2008-03-27 
$12,900,000.00 
$13,400,000.00 
$500,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
CARUSO 
DIRECTOR
DIASOME PHARMACEUTICALS LLC   |  NITRIC BIOTHERAPEUTICS, INC.   |  DIASOME PHARMACEUTICALS, INC.
BRENDA 
 
GAVIN 
DIRECTOR
DIASOME PHARMACEUTICALS LLC   |  TETRALOGIC PHARMACEUTICALS CORP   |  BIOLEAP, INC.
ROBERT 
 
GEHO 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DIASOME PHARMACEUTICALS LLC   |  DIASOME PHARMACEUTICALS, INC.
W. 
BLAIR 
GEHO 
EXECUTIVE OFFICER, DIRECTOR
DIASOME PHARMACEUTICALS LLC   |  DIASOME PHARMACEUTICALS, INC.
W. BLAIR 
 
GEHO 
DIRECTOR
DIASOME PHARMACEUTICALS, INC.
DEVANG 
 
KANTESARIA 
DIRECTOR
DIASOME PHARMACEUTICALS LLC   |  VALLEY FORGE CAPITAL, L.P.   |  VALLEY FORGE CAPITAL OFFSHORE LTD.
HELGA 
 
KAUTSKY 
EXECUTIVE OFFICER
TETRALOGIC PHARMACEUTICALS CORP   |  DIASOME PHARMACEUTICALS, INC.
FRANK 
 
MCCANEY 
DIRECTOR
DIASOME PHARMACEUTICALS, INC.   |  ALLEVI, INC.
THOMAS 
 
MCDONALD 
DIRECTOR
EDEN ROCK MONTENEGRO, LLC   |  MCDONALD HEALTHSPOT LLC   |  DIASOME PHARMACEUTICALS, INC.   |  JAGUAR PARTNERS ASIA L.P.   |  JPA FUND HOLDINGS, L.P.   |  GENOMATICA INC   |  MANOJO, INC.
MICHELE 
 
OLLIER 
DIRECTOR
NORMOXYS INC   |  AEGERION PHARMACEUTICALS, INC.   |  LINGUAFLEX, INC.   |  NORMOXYS, INC.   |  MINERVA NEUROSCIENCES, INC.   |  MEDICXI GROWTH I LP   |  DIASOME PHARMACEUTICALS, INC.   |  MEDICXI III LP   |  MEDICXI SECONDARY I LP   |  PALLADIO BIOSCIENCES, INC.
COSME 
 
ORDONEZ 
DIRECTOR
CICLOFILIN PHARMACEUTICALS INC.   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI   |  AEGIS DELIVERS OPPORTUNITY FUND LLC   |  AQUYRE BIOSCIENCES, INC.   |  AEGIS SPECIAL SITUATIONS FUND, LLC - SERIES MEDTECH XIII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VI   |  DIASOME PHARMACEUTICALS, INC.
MARC 
 
PENN 
DIRECTOR
JUVENTAS THERAPEUTICS INC   |  DIASOME PHARMACEUTICALS, INC.   |  KEYSTONE BIO, INC.   |  INOMAGEN THERAPEUTICS, INC.   |  FOMENT BIO, INC.
LEN 
 
ROSENBERG 
EXECUTIVE OFFICER, DIRECTOR
DIASOME PHARMACEUTICALS LLC
PETER 
 
TOLLMAN 
DIRECTOR
DIASOME PHARMACEUTICALS, INC.
GUISEPPE 
 
ZOCCO 
DIRECTOR
VIRTUALLOGIX INC   |  DIASOME PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-15
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
2023-06-30
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-22 
2022-09-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-26 
2020-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-09-21 
2020-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-17 
2018-10-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-12 
2017-01-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-16 
2009-04-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2008-03-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#